Mar 9, 2022 08:00AM
Feb 3, 2022 09:12AM
Feb 3, 2022 08:01AM
Feb 3, 2022 08:00AM
Sep 8, 2020 08:00AM
Aug 28, 2020 04:01PM
Aug 28, 2020 04:00PM Lipocine Provides Regulatory Update for TLANDO™
Aug 6, 2020 08:00AM
Aug 3, 2020 08:03AM
Aug 3, 2020 08:00AM
Jul 13, 2020 08:03AM
Jul 13, 2020 08:00AM
May 15, 2020 08:00AM
May 13, 2020 08:05AM Lipocine (LPCN) Announces Treatment Potential of LPCN 1144 Demonstrated in Pre-Clinical NASH and Hepatic Fibrosis Model
May 13, 2020 08:00AM
May 7, 2020 08:00AM
May 5, 2020 08:10AM
May 5, 2020 08:00AM
Apr 17, 2020 08:05AM
Apr 17, 2020 08:00AM
Apr 9, 2020 08:20AM Lipocine (LPCN) Announces US Court of Appeals for Federal Circuit Affirms Decision of USPTO
Apr 9, 2020 08:00AM
Mar 26, 2020 08:00AM
Mar 13, 2020 08:00AM
Mar 4, 2020 08:00AM
Feb 24, 2020 07:00AM
Feb 24, 2020 06:59AM
Aug 7, 2019 08:00AM Lipocine Announces Second Quarter 2019 Financial and Operational Results
May 14, 2019 08:10AM
May 14, 2019 08:00AM
May 7, 2018 08:00AM
Mar 12, 2018 08:00AM
Feb 27, 2018 08:43AM
Feb 27, 2018 08:22AM
Jan 11, 2018 09:19AM Pre-Open Movers 01/11: (SECO) (NBEV) (MGI) Higher; (LPCN) (HMNY) (APPN) Lower (more...)
Jan 10, 2018 06:01PM
Jan 10, 2018 04:40PM
Jan 10, 2018 04:28PM
Nov 17, 2017 09:27AM
Nov 17, 2017 08:07AM
Nov 17, 2017 08:00AM
Nov 8, 2017 08:00AM Lipocine Announces Financial and Operational Results for the Third Quarter and Nine Months Ended September 30, 2017
Oct 18, 2017 08:11AM
Oct 18, 2017 08:00AM
Sep 20, 2017 08:01AM
Sep 20, 2017 08:00AM
Aug 14, 2017 08:01AM
Aug 14, 2017 08:00AM
Aug 9, 2017 08:18AM Lipocine (LPCN) Resubmits NDA for Oral Testosterone Product Candidate, LPCN 1021, for Treatment of Hypogonadism
Aug 9, 2017 08:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All